Aldosteronism in Heart Failure: A Proinflammatory / Fibrogenic Cardiac Phenotype. Search for Biomarkers and Potential Drug Targets

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|4|6|505-516

ISSN： 1389-4501

Source： Current Drug Targets, Vol.4, Iss.6, 2003-08, pp. : 505-516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammatory Biomarkers and Therapeutic Targets in Heart Failure

By  

Current Medicinal Chemistry, Vol. 22, Iss. 23, 2015-01 ,pp. : 2716-2726

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Mitochondrial Dysfunction in Heart Failure and Potential Therapeutic Targets

By  

Current Pharmaceutical Design, Vol. 22, Iss. 31, 2016-09 ,pp. : 4752-4762

Bentham Science Publishers

Access to resources Recommend Favorite

The Prevalence of Potential Drug-Drug Interactions in Patients with Heart Failure at Hospital Discharge

By Straubhaar Bernhard   Krähenbühl Stephan   Schlienger Raymond G.  

Drug Safety, Vol. 29, Iss. 1, 2006-01 ,pp. : 79-90

Adis International

Access to resources Recommend Favorite

Novel Biomarkers Assessing Renal Function in Heart Failure: Relation to Inflammatory Status and Cardiac Remodelling

By  

Current Medicinal Chemistry, Vol. 21, Iss. 34, 2014-11 ,pp. : 3976-3983

Bentham Science Publishers

Access to resources Recommend Favorite

Biomarkers Downstream of RAS: A Search for Robust Transcriptional Targets

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 858-868

Bentham Science Publishers

Access to resources Recommend Favorite